NCT06858358 Robotic Medial Congruent Vs. Conventional Medial Pivot TKA
| NCT ID | NCT06858358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures |
| Condition | Knee Osteoarthristis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-02-24 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-02-24 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter, prospective cohort study will evaluate whether Robotic-Assisted total knee arthroplasty (RATKA) with a Medial Congruent implant is a successful method to improve implant alignment, insert thickness accuracy, and patient satisfaction, compared to a conventional TKA (cTKA) Medial Pivot technique. It aims to assess and compare clinical and functional outcomes in patients with severe knee osteoarthritis at 3, 6, and 12 months.
Eligibility Criteria
Inclusion Criteria: Patients with severe osteoarthritis (greater than III Ahlback) Exclusion Criteria: Patients who refuse participation in the study Low-grade osteoarthritis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06858358 clinical trial?
This trial is open to participants of all sexes, studying Knee Osteoarthristis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06858358 currently recruiting?
Yes, NCT06858358 is actively recruiting participants. Contact the research team at marianmelinte01@gmail.com for enrollment information.
Where is the NCT06858358 trial being conducted?
This trial is being conducted at Cluj-Napoca, Romania, Cluj-Napoca, Romania.
Who is sponsoring the NCT06858358 clinical trial?
NCT06858358 is sponsored by George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures. The trial plans to enroll 300 participants.